PHARMACOLOGICAL EVALUATION OF ANTI-OBESITY ACTIVITY WITH ETANOLIC EXTRACT OF HYGROPHILA AURICULATA IN RATS
Obesity is a chronic metabolic disorder characterized by excessive accumulation of body fat and is associated with an increased risk of cardiovascular diseases, type 2 diabetes mellitus, dyslipidemia, hypertension, and other metabolic complications. Despite the availability of pharmacological interventions, the long-term use of anti-obesity drugs is often limited by adverse effects, necessitating the search for safer and more effective natural alternatives. The present study was undertaken to evaluate the anti-obesity activity of the ethanolic extract of Hygrophila auriculata in high-fat diet (HFD)-induced obese Wistar albino rats.Preliminary phytochemical screening of the ethanolic extract revealed the presence of alkaloids, flavonoids, phenolic compounds, tannins, saponins, terpenoids, steroids, glycosides, proteins, carbohydrates, amino acids, and fixed oils. Obesity was induced by feeding rats a high-fat diet for 6–8 weeks. The animals were divided into six groups: normal control, HFD control, standard (Orlistat, 10 mg/kg), and three treatment groups receiving the ethanolic extract of Hygrophila auriculata at doses of 100, 200, and 400 mg/kg orally for 28 consecutive days. At the end of the treatment period, body weight, body mass index (BMI), Lee index, serum lipid profile [total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL)], and oxidative stress markers [malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH)] were evaluated. Administration of the high-fat diet produced a significant increase in body weight, BMI, Lee index, TC, TG, LDL, VLDL, and MDA levels, along with a significant reduction in HDL, SOD, CAT, and GSH levels compared with the normal control group. Treatment with the ethanolic extract significantly and dose-dependently reduced body weight gain, BMI, Lee index, TC, TG, LDL, VLDL, and MDA levels while significantly increasing HDL, SOD, CAT, and GSH levels. Among the tested doses, the 400 mg/kg extract produced the most pronounced effects and showed efficacy comparable to the standard drug, Orlistat.the present study demonstrate that the ethanolic extract of Hygrophila auriculata possesses significant anti-obesity, antihyperlipidemic, and antioxidant activities in high-fat diet-induced obese rats. These beneficial effects are likely attributable to the synergistic action of its phytoconstituents, particularly flavonoids, phenolic compounds, saponins, terpenoids, and phytosterols, which regulate lipid metabolism and protect against oxidative stress. The study provides scientific evidence supporting the traditional use of Hygrophila auriculata in the management of obesity and suggests that it may serve as a promising natural therapeutic agent for the prevention and treatment of obesity and its associated metabolic disorders. However, further studies are required to isolate the active constituents, elucidate the underlying molecular mechanisms, and establish its long-term safety and clinical efficacy.
Authors
- A. Srinivasa Rao
- AV. Kishore Babu
- M. Manusha
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24387329
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00